يعرض 1 - 20 نتائج من 25 نتيجة بحث عن '"Sebastian Ueckert"', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المؤلفون: Sebastian Ueckert

    المصدر: CPT: Pharmacometrics & Systems Pharmacology, Vol 7, Iss 4, Pp 205-218 (2018)

    مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950

    وصف الملف: electronic resource

  5. 5
  6. 6
  7. 7
  8. 8

    المؤلفون: France Mentré, Sebastian Ueckert

    المساهمون: Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), This work was supported by the Innovative Medicines Initiative Joint Undertakingunder grant agreement no. 115156, resources of which are composed of nancial contri-butions from the European Unions Seventh Framework Program (FP7/2007 2013) andEFPIA companies in-kind contribution. The DDMoRe project is also supported by -nancial contribution from academic and SME partners. This work does not necessarilyrepresent the view of all DDMoRe partners.This work has also received funding from the European Unions 7th Framework Pro-gramme for research, technological development and demonstration under Grant Agree-ment no. 602552., European Project: DDMoRe, European Project: FP7/2007 2013, Comets, Emmanuelle, Drug Disease Model Resources - DDMoRe - INCOMING, European Unions Seventh Framework Program - FP7/2007 2013 - INCOMING

    المصدر: Computational Statistics and Data Analysis
    Computational Statistics and Data Analysis, Elsevier, 2016, ⟨10.1016/j.csda.2016.10.011⟩

    وصف الملف: application/pdf

  9. 9
  10. 10
  11. 11

    المساهمون: Roche Pharma Research and Early Development [Basel] ( pRED ), F. Hoffmann-La Roche [Basel], Infection, Antimicrobiens, Modélisation, Evolution ( IAME ), Université Paris 13 ( UP13 ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), INSTITUT ROCHE, Faculty of pharmacy / Department of Pharmaceutical Biosciences / Division of Pharmacokinetics and drug therapy, Uppsala University, INSTITUT Roche, This work was financed by a CIFRE agreement (Conventions Industrielles de Formation par la Recherche) and was conducted under the supervision of the ANRT (Association Nationale Recherche Technologie). The CIFRE agreement is a partnership between a public laboratory and a company, here the UMR 1137 and INSTITUT ROCHE, respectively., Comets, Emmanuelle, Roche Pharma Research and Early Development [Basel] (pRED), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)

    المصدر: The AAPS Journal
    The AAPS Journal, 2018, 20 (3), pp.56. 〈10.1208/s12248-018-0205-x〉
    AAPS Journal
    AAPS Journal, American Association of Pharmaceutical Scientists, 2018, 20 (3), pp.56. ⟨10.1208/s12248-018-0205-x⟩

    وصف الملف: application/pdf

  12. 12
  13. 13
  14. 14

    المساهمون: Comets, Emmanuelle, Roche Pharma Research and Early Development [Basel] (pRED), F. Hoffmann-La Roche [Basel], Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Institut ROCHE [Boulogne-Billancourt], Roche S.A.S, Department of Pharmaceutical Biosciences [Uppsala, Sweden], Uppsala University, This work was financed by F-Hoffmann- La Roche Ltd. We are grateful to the PPMI – a public-private partnership – funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners, including Abbvie, Inc., Eli Lilly and Company and its subsidiary company Avid Radiopharmaceuticals, Biogen Idec Inc., Bristol-MyersSquibb Company, Covance, Inc., F-Hoffmann- La Roche Ltd and its subsidiary company Genetech, Inc., GE Healthcare, Servier, GlaxoSmithKline plc., H. Lundbeck A/S, Merck & Co., Inc., Meso Scale Diagnostics, LLC., Pfizer Inc., Piramal Imaging, and UCB. for providing access to the PPMI cohort.

    المصدر: Pharmaceutical Research
    Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2017, 34 (10), pp.2109-2118. ⟨10.1007/s11095-017-2216-1⟩

    وصف الملف: application/pdf

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    المساهمون: HAL-UPMC, Gestionnaire, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)

    المصدر: Biostatistics
    Biostatistics, Oxford University Press (OUP), 2016, ⟨10.1093/biostatistics/kxw020⟩

    وصف الملف: applicaton/octet-stream

  20. 20